LexDanaLexDanabeta
Inventor

Florence Raynaud

Inventor
London, GB

Overview

7→
Patents
2006–2014
Patent span
Human necessities
Primary field (CPC A)

Patents· 7 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes20%
Y02ATechnologies for adaptation to climate change10%
PatentTitleYear
8,846,696'Purine derivatives'20147,674,823'DNA-PK inhibitors'20107,612,079'2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders'20097,582,642'Purine derivatives'20097,544,689'Purine derivatives'20097,226,918'DNA-PK inhibitors'20077,105,518'Thiopyrane-4-ones as DNA protein kinase inhibitors'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2014Patents assigned to CANCER REC TECH LTD (7)· patent assignee history
2006–2010Based in Surrey, GB· patent location history
2009–2014Patents assigned to CYCLACEL LTD (4)· patent assignee history
2009–2014Based in London, GB· patent location history
2014Patents assigned to FISCHER PETER MARTIN (1)· patent assignee history
2014Patents assigned to JARMAN MICHAEL (1)· patent assignee history
2014Patents assigned to MCDONALD EDWARD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CANCER REC TECH LTD72006–2014
CYCLACEL LTD42009–2014
FISCHER PETER MARTIN12014
JARMAN MICHAEL12014
MCDONALD EDWARD12014
Locations
LocationPatentsSpan
London, GB42009–2014
Surrey, GB32006–2010